top of page
the next generation of novel immunotherapies

redalpine

immunos

immunos is addressing this challenge by developing a platform technology for immunomodulatory proteins that can re-awaken the body’s own defense system. immunos' mission is to develop the next generation of novel immunotherapies that will improve the lives of patients with serious diseases.

next generation of novel immunotherapies

the immune system’s natural capacity to detect and eliminate abnormal cells may prevent the development of many cancers. however, cancer cells are often able to avoid detection and destruction by the immune system.

helping the immune system fight cancer

rac III
biotech
2019
2014
fund
sector
invested in
founded

Immune-Boost for ImmunOs Therapeutics: CHF 15M Series A Round

Dec 10, 2019

ImmunOs Therapeutics AG raises CHF 71M in Series B Financing

Jun 7, 2022

related stories

bottom of page